Histamine

Histamine

SCHEMBL3981179

NCCc1c[nH]cn1.c1ccc(C(c2ccccc2)N2CCNCC2)cc1

nearest known ligand 0.56

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

HRH1

The experimentally established mechanism targets of Histamine. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 10)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 1/20 0.56
KMT2A Q03164 1/20 0.56
OPRD1 P41143 14/20 0.47
SLC6A4 P31645 2/20 0.43
USP2 O75604 1/20 0.43
CYP2C9 P11712 1/20 0.43
CYP2C19 P33261 1/20 0.43
OPRM1 P35372 1/20 0.42
CYP2D6 P10635 1/20 0.40
CYP19A1 P11511 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9720665 0.76 ATM (0.51) MEN1KMT2AOPRD1USP2OPRM1
Histamine SCHEMBL4064919 0.75 HRH1 (0.38)
SCHEMBL219432 0.75 MEN1 (1.00) MEN1KMT2AOPRD1SLC6A4USP2
Histamine SCHEMBL28074178 0.75 HRH1 (0.42) CYP2C9CYP2C19
SCHEMBL2794662 0.75 MEN1 (1.00) MEN1KMT2AOPRD1SLC6A4USP2
Histamine SCHEMBL29158012 0.74 HRH4 (0.34) CYP2C9CYP2C19
Hydrochloric Acid SCHEMBL7006476 0.73 MEN1 (0.96) MEN1KMT2AOPRD1SLC6A4USP2
SCHEMBL27485345 0.73 MEN1 (0.96) MEN1KMT2AOPRD1SLC6A4USP2
Hydrochloric Acid SCHEMBL11456225 0.73 MEN1 (0.96) MEN1KMT2AOPRD1SLC6A4USP2
Fluoride SCHEMBL27959930 0.73 MEN1 (0.96) MEN1KMT2AOPRD1SLC6A4USP2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2009061465-A1 CHEWABLE FORMULATIONS TEVA PHARMACEUTICAL INDUSTRIES LTD. (IL) 2009-05-14 WO disclosed